Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kåre Sander

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|September 26, 2013
[Cardiac transplantation]Finn Gustafsson, Kåre Sander
Journal of the American College of Cardiology|June 6, 2009
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II)Jolanta Klovaite, Finn Gustafsson, Svend A Mortensen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 30, 2009
Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II)Mads Andersen, Regitze Videbaek, Søren Boesgaard, et al.
Ugeskrift for Laeger|October 24, 2007
[Percutaneous assist device during acute heart failure]Matias Greve Lindholm, Thomas Engstrøm, Kristian Wachtell, et al.
Ugeskrift for Laeger|October 24, 2007
[Destination therapy in end-stage heart failure. A possible alternative to heart transplantation?]Peter Skov Olsen, Kåre Sander, Peter Bo Hansen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 12, 2010
Primary cardiac tumors: a clinicopathologic evaluation of four casesCharlotte Winther, Vera Timmermans-Wielenga, Søren Daugaard, et al.
Congestive Heart Failure (Greenwich, Conn.)|April 24, 2012
Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failureJon M Appel, Kåre Sander, Peter B Hansen, et al.
Ugeskrift for Laeger|May 18, 2010
[Normalisation of left ventricular function after 13 months of mechanical circulatory support]Finn Gustafsson, Jacob E Møller, Peter B Hansen, et al.
European Journal of Heart Failure|November 2, 2012
Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunctionNis Stride, Steen Larsen, Martin Hey-Mogensen, et al.
Ugeskrift for Laeger|October 24, 2007
[The Mechanical Heart--HeartMate 1--Danish results]Kåre Sander, Claus B Andersen, Søren Boesgaard, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|September 26, 2013
[Cardiac transplantation]Finn Gustafsson, Kåre Sander
Journal of the American College of Cardiology|June 6, 2009
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II)Jolanta Klovaite, Finn Gustafsson, Svend A Mortensen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 30, 2009
Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II)Mads Andersen, Regitze Videbaek, Søren Boesgaard, et al.
Ugeskrift for Laeger|October 24, 2007
[Percutaneous assist device during acute heart failure]Matias Greve Lindholm, Thomas Engstrøm, Kristian Wachtell, et al.
Ugeskrift for Laeger|October 24, 2007
[Destination therapy in end-stage heart failure. A possible alternative to heart transplantation?]Peter Skov Olsen, Kåre Sander, Peter Bo Hansen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 12, 2010
Primary cardiac tumors: a clinicopathologic evaluation of four casesCharlotte Winther, Vera Timmermans-Wielenga, Søren Daugaard, et al.
Congestive Heart Failure (Greenwich, Conn.)|April 24, 2012
Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failureJon M Appel, Kåre Sander, Peter B Hansen, et al.
Ugeskrift for Laeger|May 18, 2010
[Normalisation of left ventricular function after 13 months of mechanical circulatory support]Finn Gustafsson, Jacob E Møller, Peter B Hansen, et al.
European Journal of Heart Failure|November 2, 2012
Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunctionNis Stride, Steen Larsen, Martin Hey-Mogensen, et al.
Ugeskrift for Laeger|October 24, 2007
[The Mechanical Heart--HeartMate 1--Danish results]Kåre Sander, Claus B Andersen, Søren Boesgaard, et al.
Pageof 2